Endometriosis-associated ovarian cancer: What have we learned so far?

Marta Herreros‐Villanueva; M Herreros-Villanueva; Chih-Chieh Chen; Eing‐Mei Tsai; Eing-Mei Tsai; Tze‐Kiong Er; Tze-Kiong Er

doi:10.1016/j.cca.2019.02.016

Endometriosis-associated ovarian cancer: What have we learned so far?

Marta Herreros‐Villanueva, M Herreros-Villanueva, Chih-Chieh Chen, Eing‐Mei Tsai, Eing-Mei Tsai, Tze‐Kiong Er, Tze-Kiong Er

Clinica chimica acta; international journal of clinical chemistry · 2019 · vol. 493 , pp. 63–72 · doi:10.1016/j.cca.2019.02.016 · PMID:30776361 · W2912964289

review OA: closed CC0 ⤵ 37 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This review consolidates current knowledge on the association between endometriosis and ovarian cancer, examining epidemiological links, biological mechanisms, and potential therapeutic strategies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Ovarian Neoplasms Endometriosis Female Humans Ovarian Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (37)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-04T00:00:01.174412+00:00
pubmed: last seen: 2026-05-13T22:23:01.605684+00:00
unpaywall: last seen: 2026-06-02T02:00:03.124865+00:00

License: CC0 · commercial use OK

[1] Aberrant Methylation of the E-Cadherin Gene Promoter Region in Endometrium and Ovarian Endometriotic Cysts of Patients with Ovarian Endometriosis via openalex

[2] Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients via openalex

[3] A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. via openalex

[4] A polymorphism in a let‐7 microRNA binding site of KRAS in women with endometriosis via openalex

[5] A Review of the Epigenetic Contributions to Endometriosis via openalex

[6] A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update via openalex

[7] Aromatase inhibitor regulates let-7 expression and let-7f–induced cell migration in endometrial cells from women with endometriosis via openalex

[8] Association between endometriosis and cancer: A comprehensive review and a critical analysis of clinical and epidemiological evidence via openalex

[9] Association between ovarian cancer and advanced endometriosis via openalex

[10] Association of Pelvic Inflammatory Disease with Risk of Endometriosis: A Nationwide Cohort Study Involving 141,460 Individuals via openalex

[11] Atlas of endometriosis via openalex

[12] Cancer-Associated Mutations in Endometriosis without Cancer via openalex

[13] Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis via openalex

[14] Chemokine growth-regulated-α: a possible role in the pathogenesis of endometriosis via openalex

[15] Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the “old” complement pathway via openalex

[16] Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium via openalex

[17] Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer via openalex

[18] Concentrations of Interferon‐γ‐Induced Protein‐10 (IP‐10), an Antiangiogenic Substance, are Decreased in Peritoneal Fluid of Women with Advanced Endometriosis via openalex

[19] Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress via openalex

[20] Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis via openalex

[21] Dendritic Cells Attenuate the Early Establishment of Endometriosis-Like Lesions in a Murine Model via openalex

[22] Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis via openalex

[23] Dioxin concentrations in women with endometriosis via openalex

[24] Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder via openalex

[25] ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN via openalex

[26] Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why via openalex

[27] Endometriosis via openalex

[28] Endometriosis via openalex

[29] Endometriosis via openalex

[30] Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development via openalex

[31] Endometriosis and ovarian cancer: links, risks, and&nbsp;challenges faced via openalex

[32] Endometriosis-associated Ovarian Cancers via openalex

[33] Environmental Dioxins and Endometriosis via openalex

[34] Environmental factors and endometriosis via openalex

[35] Environmental factors and endometriosis via openalex

[36] Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis via openalex

[37] Expression of Natural Cytotoxicity Receptors on Peritoneal Fluid Natural Killer Cell and Cytokine Production by Peritoneal Fluid Natural Killer Cell in Women with Endometriosis via openalex

[38] Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives via openalex

[39] Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine via openalex

[40] <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex

[41] Iatrogenic endometriosis harbors somatic cancer-driver mutations via openalex

[42] Iatrogenic endometriosis harbors somatic cancer-driver mutations via openalex

[43] Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis via openalex

[44] IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors via openalex

[45] Imbalance in Cytokines from Interleukin‐1 Family – Role in Pathogenesis of Endometriosis via openalex

[46] Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex

[47] Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis via openalex

[48] Independent development of endometrial epithelium and stroma within the same endometriosis via openalex

[49] Involvement of immune cells in the pathogenesis of endometriosis via openalex

[50] <i>PIK3CA</i> mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma via openalex

[51] KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis via openalex

[52] Local Cytokines in Endometrial Tissue: The Role of Interleukin‐8 in the Pathogenesis of Endometriosis via openalex

[53] Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma. via openalex

[54] Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis via openalex

[55] Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. via openalex

[56] micro <scp>RNA</scp> Let‐7b: A Novel treatment for endometriosis via openalex

[57] miR-191 Modulates Malignant Transformation of Endometriosis Through Regulating TIMP3 via openalex

[58] MiR‑381 regulates cell motility, growth and colony formation through PIK3CA in endometriosis‑associated clear cell and endometrioid ovarian cancer via openalex

[59] Mismatch repair system in endometriotic tissue and eutopic endometrium of unaffected women. via openalex

[60] Modulation of neutrophil apoptosis by plasma and peritoneal fluid from patients with advanced endometriosis via openalex

[61] Natural Killer Cells: Key Players in Endometriosis via openalex

[62] New insights in the pathophysiology of ovarian cancer and implications for screening and prevention via openalex

[63] Novel CTCF mutations in Chinese patients with ovarian endometriosis via openalex

[64] Novel insights on the malignant transformation of endometriosis into ovarian carcinoma via openalex

[65] Novel TRERF1 mutations in Chinese patients with ovarian endometriosis via openalex

[66] PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis via openalex

[67] Pathogenesis of endometriosis via openalex

[68] Pathophysiology and Immune Dysfunction in Endometriosis via openalex

[69] Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex

[70] Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis via openalex

[71] Peritoneal natural killer cytotoxicity and CD25+CD3+ lymphocyte subpopulation are decreased in women with stage III–IV endometriosis via openalex

[72] Possible involvement of <i>hMLH1, p16</i><sup><i>INK4a</i></sup> and <i>PTEN</i> in the malignant transformation of endometriosis via openalex

[73] Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors via openalex

[74] Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery via openalex

[75] Role of miR‑449b‑3p in endometriosis via effects on endometrial stromal cell proliferation and angiogenesis via openalex

[76] RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis via openalex

[77] <scp>miRNA</scp> ‐199a‐5p regulates <scp>VEGFA</scp> in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis via openalex

[78] Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis via openalex

[79] Stem cells in endometrium and their role in the pathogenesis of endometriosis via openalex

[80] Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer via openalex

[81] The development of endometriosis in a murine model is dependent on the presence of dendritic cells via openalex

[82] The Endometriotic Tumor Microenvironment in Ovarian Cancer via openalex

[83] Theories on the Pathogenesis of Endometriosis via openalex

[84] The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis via openalex

[85] The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different via openalex

[86] The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis via openalex

[87] The Role of p53 Mutation in the Carcinomas Arising from Endometriosis via openalex

[88] Tumor necrosis factor-α but not interleukin-1β or interleukin-8 concentrations correlate with angiogenic activity of peritoneal fluid from patients with minimal to mild endometriosis via openalex

[89] Up-regulation of ribosome biogenesis by <i>MIR196A2</i> genetic variation promotes endometriosis development and progression via openalex

[90] Vascular endothelial growth factor A and C gene expression in endometriosis via openalex

[91] Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex

[92] Whole-exome sequencing of endometriosis identifies frequent alterations in genes involved in cell adhesion and chromatin-remodeling complexes via openalex

[93] W6657493500 via openalex

[94] W6670777294 via openalex

[95] W6712945788 via openalex

[96] W6715711656 via openalex

[97] W6749376469 via openalex

[98] W6754038347 via openalex

[99] W6755000090 via openalex

[100] W6755901209 via openalex